Guidance from the Centers for Disease Control (CDC) published in 2024 also supports the correlation between weight loss and lowering risk for T2D
Therapy with a GLP-1 RA or sodium-glucose cotransporter 2 inhibitor (SGLT2 inhibitor) that has proven CV benefit is recommended for initial therapy, with or without metformin based on glycemic needs, in patients with indicators of high-risk or established CV disease
Scientists at Spains Catholic University of Murcia have discovered two plant extracts that can potentially be used to make GLP-1 agonist pills, while Californias One Bio recently raised $27M for its tech that extracts invisible and tasteless fibres from plants for use in GLP-1-friendly foods (among other products)
Orforglipron for Maintenance of Body Weight Reduction: The Double-Blind, Randomized Phase 3b ATTAIN-MAINTAIN Trial
If bubbles appear, push the fluid back into the vial and redraw more slowly
Lipotropic injections typically include: Lipotropic injections offer more than just weight management benefits